CellCyte Genetics Corp. (CCYG) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for CellCyte Genetics Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 156,221 54,042 15,685 14,513 16,218
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 156,221 54,042 15,685 14,513 16,218
Depreciation 148,717 46,536 8,181 7,009 0
Amortization of Intangibles 7,504 7,506 7,504 7,504 16,218
Gross Income (156,221) (54,042) (15,685) (14,513) (16,218)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.17M 561,821 291,126 118,147 107,931
Research & Development 0 0 0 0 0
Other SG&A 1.17M 561,821 291,126 118,147 107,931
Other Operating Expense 0 140,091 0 0 0
Unusual Expense (53,547) 0 0 (749,539) 0
EBIT after Unusual Expense 53,547 0 0 749,539 0
Non Operating Income/Expense (68,792) (4,819) 0 1,985 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 76,530 38,459 52,591 33,037 39,889
Gross Interest Expense 76,530 38,459 52,591 33,037 39,889
Interest Capitalized 0 0 0 0 0
Pretax Income (1.42M) (799,232) (359,402) 585,827 (164,038)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income (1.42M) (799,232) (359,402) 585,827 (164,038)
Minority Interest Expense 0 0 0 0 0
Net Income (1.42M) (799,232) (359,402) 585,827 (164,038)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.42M) (799,232) (359,402) 585,827 (164,038)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.42M) (799,232) (359,402) 585,827 (164,038)
EPS (Basic) (0.02) (0.01) 0.00 0.01 ()
Basic Shares Outstanding 66.49M 73.7M 75.83M 82.33M 82.33M
EPS (Diluted) (0.02) (0.01) 0.00 0.01 ()
Diluted Shares Outstanding 66.49M 73.7M 75.83M 88.79M 82.33M
EBITDA (1.17M) (701,912) (291,126) (118,147) (107,931)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for CellCyte Genetics Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 156,221 54,042 15,685 14,513 16,218
COGS excluding D&A 0 0 0 0 0
Depreciation & Amortization Expense 156,221 54,042 15,685 14,513 16,218
Depreciation 148,717 46,536 8,181 7,009 0
Amortization of Intangibles 7,504 7,506 7,504 7,504 16,218
Gross Income (156,221) (54,042) (15,685) (14,513) (16,218)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 1.17M 561,821 291,126 118,147 107,931
Research & Development 0 0 0 0 0
Other SG&A 1.17M 561,821 291,126 118,147 107,931
Other Operating Expense 0 140,091 0 0 0
Unusual Expense (53,547) 0 0 (749,539) 0
EBIT after Unusual Expense 53,547 0 0 749,539 0
Non Operating Income/Expense (68,792) (4,819) 0 1,985 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 76,530 38,459 52,591 33,037 39,889
Gross Interest Expense 76,530 38,459 52,591 33,037 39,889
Interest Capitalized 0 0 0 0 0
Pretax Income (1.42M) (799,232) (359,402) 585,827 (164,038)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income (1.42M) (799,232) (359,402) 585,827 (164,038)
Minority Interest Expense 0 0 0 0 0
Net Income (1.42M) (799,232) (359,402) 585,827 (164,038)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (1.42M) (799,232) (359,402) 585,827 (164,038)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (1.42M) (799,232) (359,402) 585,827 (164,038)
EPS (Basic) (0.02) (0.01) 0.00 0.01 ()
Basic Shares Outstanding 66.49M 73.7M 75.83M 82.33M 82.33M
EPS (Diluted) (0.02) (0.01) 0.00 0.01 ()
Diluted Shares Outstanding 66.49M 73.7M 75.83M 88.79M 82.33M
EBITDA (1.17M) (701,912) (291,126) (118,147) (107,931)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
